Sale!

UCHL1 Gene PARK5 Parkinson Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The UCHL1 Gene PARK5 Parkinson Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the UCHL1 gene, which have been associated with a rare familial form of Parkinson’s disease. This gene plays a crucial role in the pathogenesis of Parkinson’s disease by influencing the ubiquitin-proteasome system, crucial for protein degradation and clearance in neural cells. Mutations in the UCHL1 gene can lead to abnormal protein accumulation, contributing to neurodegeneration observed in Parkinson’s disease.

The test is priced at 4400 AED and involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing techniques. The aim is to detect any genetic alterations in the UCHL1 gene that may indicate an increased risk of developing Parkinson’s disease, particularly in individuals with a family history of the condition.

By identifying these genetic markers early, the UCHL1 Gene PARK5 Parkinson Genetic Test can provide crucial information for risk assessment and potential early intervention strategies. It’s an important tool in the management and understanding of Parkinson’s disease, offering hope for those seeking to understand their genetic predisposition to this challenging neurodegenerative disorder.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

UCHL1 Gene PARK5 Parkinson Genetic Test

Introduction

The UCHL1 gene is a gene that codes for the protein ubiquitin carboxyl-terminal hydrolase L1. This protein is involved in the regulation of the ubiquitin-proteasome system, which is responsible for the degradation of damaged or misfolded proteins in cells. PARK5 refers to a specific subtype of Parkinson’s disease, also known as autosomal dominant juvenile Parkinsonism. This subtype is associated with mutations in the UCHL1 gene.

Test Details

A UCHL1 gene PARK5 Parkinson NGS genetic test involves sequencing the UCHL1 gene using NGS technology to identify any mutations or variations that may be associated with Parkinson’s disease, specifically the PARK5 subtype. This test can help diagnose Parkinson’s disease and provide valuable information for personalized treatment and management of the condition.

Components and Price

Test Name: UCHL1 Gene PARK5 Parkinson Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for UCHL1 Gene PARK5 Parkinson NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with UCHL1 Gene PARK5 Parkinson

For more information and to book an appointment, please contact DNA Labs UAE.

Test Name UCHL1 Gene PARK5 Parkinson Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for UCHL1 Gene PARK5 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with UCHL1 Gene PARK5 Parkinson
Test Details

The UCHL1 gene is a gene that codes for the protein ubiquitin carboxyl-terminal hydrolase L1. This protein is involved in the regulation of the ubiquitin-proteasome system, which is responsible for the degradation of damaged or misfolded proteins in cells.

PARK5 refers to a specific subtype of Parkinson’s disease, also known as autosomal dominant juvenile Parkinsonism. This subtype is associated with mutations in the UCHL1 gene.

NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that allows for the rapid sequencing of large amounts of genetic material. It can be used to identify mutations or variations in genes, including the UCHL1 gene, that may be associated with Parkinson’s disease.

A UCHL1 gene PARK5 Parkinson NGS genetic test involves sequencing the UCHL1 gene using NGS technology to identify any mutations or variations that may be associated with Parkinson’s disease, specifically the PARK5 subtype. This test can help diagnose Parkinson’s disease and provide valuable information for personalized treatment and management of the condition.